Pulsenmore

Pulsenmore R&D per Employee

The R&D Spending per Employee of Pulsenmore (PLSM.TA) as of Nov 21, 2026 is 231,333.33 ILS. In the previous year, R&D Spending per Employee was 251,549.07 ILS — a change of -8.04% (lower).

R&D per Employee

231,333.33ILS

YoY

-8.04%

Last updated:

R&D Spending per Employee of Pulsenmore is 2025 231,333.33 ILS. R&D Spending per Employee of Pulsenmore was 2024 251,549.07 ILS. It decreases by -8.04% lower compared to the previous year.

The Pulsenmore R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2019
36,488.49 ILS
Jan 1, 2020
137,189.91 ILS
Jan 1, 2021
141,428.32 ILS
Jan 1, 2022
377,005.61 ILS
Jan 1, 2023
400,867.64 ILS
Jan 1, 2024
251,549.07 ILS
Jan 1, 2025
231,333.33 ILS
The Pulsenmore R&D per Employee history
YEARR&D per EmployeeYoY
231,333.33ILS-8.04%
251,549.07ILS-37.25%
400,867.64ILS+6.33%
377,005.61ILS+166.57%
141,428.32ILS+3.09%
137,189.91ILS+275.98%
36,488.49ILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pulsenmore Stock analysis

What does Pulsenmore do? Pulsenmore Ltd. generates revenue through the sale of its two miniaturized ultrasound systems, PulseNmore ES and PulseNmore FC, designed for home use in remote clinical diagnosis. The PulseNmore ES targets pregnant women requiring regular ultrasound monitoring, while PulseNmore FC caters to women undergoing in vitro fertilization needing follicle size assessments. Both systems integrate with smartphones, enabling patients to conduct tests at home and share results online with healthcare providers. The company also monetizes through software delivery for its devices, enhancing user experience and data management. The primary buyers of PulseNmore ES are pregnant women seeking convenient, clinic-free monitoring, and healthcare providers managing prenatal care remotely. PulseNmore FC is purchased by women undergoing in vitro fertilization, often through fertility clinics or medical centers that recommend the device. These segments value the convenience of home-based diagnostics and seamless telehealth integration without requiring in-person visits. Pulsenmore Ltd. focuses on global markets for its portable ultrasound solutions, serving patients in remote or underserved areas who benefit from telehealth-enabled diagnostics. The company’s products are positioned as cost-effective alternatives to traditional clinic visits, appealing to both end-users and healthcare institutions aiming to reduce operational costs while maintaining patient care quality. Pulsenmore is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulsenmore stock

R&D Spending per Employee of Pulsenmore is 231,333.33 ILS in 2025.

R&D Spending per Employee of Pulsenmore changed from 251,549.07 ILS to 231,333.33 ILS, representing a -8.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Pulsenmore since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Pulsenmore historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Pulsenmore

All Key Metrics — Pulsenmore